PTHLH and neoplasm: Specifically, various tumour cell-derived factors, such as interleukin 6 and PTHrP (parathyroid hormone-related protein), induce RANKL expression in osteoblasts, resulting in RANK-mediated activation of osteoclasts and consequent bone resorption.